Key Takeaways
- FDA Commissioner Martin Makary suggested combining all of FDA's adverse event reporting systems, currently divided by product area into separate systems, into one.
- While many FDA experts have called for improvements to the agency's post-market surveillance capabilities, this particular change called for by Makary was not seen as adding much value to FDA and could cause some problems, experts said.
- Makary also falsely argued in the 17 April interview with The Megyn Kelly Show that FDA did not properly investigate certain adverse events tied to COVID vaccines.
US Food and Drug Administration Commissioner Martin Makary is considering combining all of the agency’s adverse event reporting systems into one, a move he framed as a way to create...
Makary brought up FDA’s multiple AE systems in a lengthy 17 April interview with The Megyn Kelly Show as an example of his push to create...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?
